initial public offerings (IPOs) trading on American exchanges

Thursday, February 25, 2016

Alarm.com (ALRM) reported earnings Thur 25 Feb 2016 (a/h)

** charts after earnings **




Home security and smart-home technology provider Alarm.com (ALRM) soared Friday to a record high after raising its guidance and reporting fourth-quarter earnings late Thursday that topped expectations.

The company is a cloud-based provider of connected-home technology. Its software-as-a-service platform enables homeowners and businesses to control a broad array of connected devices through a single user interface.

Alarm.com reported Q4 revenue of $56.9 million, up 25% year over year and topping the consensus estimate of $44.1 million, as polled by Thomson Reuters. It reported earnings per share minus items of 14 cents, smashing estimates of just a penny profit.

During the quarter, Alarm.com introduced an app for Apple (AAPL) TV. The app lets users watch live feeds from video cameras around their property in real time, using the Apple TV operating system and remote control.

The company also announced voice control for lighting and smart thermostats that can be managed through the Amazon (AMZN) Echo device. With Amazon Echo and the Amazon cloud-based voice service Alexa, spoken commands — such as “turn on the living room lights” — trigger connected devices in the home.

Alarm.com stock was up 13%, near 20, in late-afternoon trading in the stock market today. It peaked earlier in the session at 22.67. Alarm.com raised $98 million with its June 25 initial public offering, pricing 7 million shares at 14, the midpoint of its range.

For 2016, Alarm.com expects revenue of $236 million to $239.5 million, well above the consensus of $232 million.

Credit Suisse analyst Michael Nemeroff raised his price target on Alarm.com stock to 25 from 22, and maintained a buy rating.

Alarm.com said that it expanded its base of dealers to 6,100, up from about 5,100 one year ago. It ended the year with 2.6 million subscribers, up 200,000 from eight months earlier.

Tuesday, February 23, 2016

Norwegian Cruise Line (NCLH) reported earnings on Tue 23 Feb 2016 (BMO)

** charts before earnings **


 



** charts after earnings **


  




Norwegian Cruise Line reports EPS in-line, misses on revs; guides Q1 EPS in-line; guides FY16 EPS in-line :
Reports Q4 (Dec) earnings of $0.51 per share, in-line with the Capital IQ Consensus of $0.51; revenues rose 31.4% year/year to $1.04 bln vs the $1.05 bln Capital IQ Consensus.
  • Co issues in-line guidance for Q1, sees EPS of $0.34-0.39 vs. $0.34 Capital IQ Consensus Estimate.
  • Co issues in-line guidance for FY16, sees EPS of $3.65-3.85 vs. $3.73 Capital IQ Consensus Estimate.

Friday, February 19, 2016

2016 has seen lowest number of US IPOs year-to-date since 2009



In 2014, the US IPO market had a record year. There were 229 companies headquartered in the United States that went public, which made up $55 billion in gross proceeds. This marked the most deals and largest aggregate amount of gross proceeds raised in a year since 2000. In 2015, the market for initial public offerings began to dry up. The count of US companies going public dropped by 40% (137 companies) compared to 2014, and total gross proceeds were essentially cut in half ($28.3 billion).

Thursday, February 18, 2016

TrueCar (TRUE) reported earnings Thur 18 Feb 2016 (a/h)

** charts before earnings ** 



 




** charts after earnings **



 




 TrueCar misses by $0.02, misses on revs; guides Q1 & FY16 revs below consensus  :
Reports Q4 (Dec) loss of $0.06 per share, $0.02 worse than the Capital IQ Consensus of ($0.04); revenues rose 14.6% year/year to $63.59 mln vs the $65.28 mln Capital IQ Consensus.
  • Co issues downside guidance for Q1, sees Q1 revs of $60-62 mln vs. $70.21 mln Capital IQ Consensus Estimate. Adjusted EBITDA is expected to be breakeven.
  • Co issues downside guidance for FY16, sees FY16 revs of $270-275 mln vs. $309.74 mln Capital IQ Consensus Estimate. Adjusted EBITDA is expected to be breakeven.
  • Franchise dealer count was 9,094 as of December 31, 2015, representing approximately 29% of all new car franchises and an increase from 8,702 as of September 30, 2015.
  • Average monthly unique visitors was 5.9 million in the fourth quarter of 2015, up from approximately 4.4 million in the fourth quarter of 2014. In FY 2015, average monthly unique visitors increased 40% to approximately 6.0 million, up from 4.3 million in FY 2014.

Wednesday, February 17, 2016

Gogo (GOGO) plummets as American threatens to dump its Wi-Fi

Gogo shares plunged today after the company disclosed that one of its biggest customers, American Airlines, said its in-flight Wi-Fi service is lacking.


The Chicago-based tech company's shares were down about 28 percent five minutes before the market was to close today.

In a regulatory filing, Gogo said: "American notified Gogo that it considers a competitor's connectivity service to offer a material improvement over our early-generation air-to-ground service with respect to a portion of American's fleet representing approximately 200 aircraft."

Gogo provides in-flight Wi-Fi for American, Delta and other airlines. The company employs more than 1,000 people at its downtown headquarters, which opened last year.

Gogo is headquartered in Chicago's West Loop at 111 N. Canal St.

Technology for providing Internet connectivity to aircraft has been evolving rapidly, from ground-based cellular to satellite-based service, which is much faster and cheaper than earlier generations of satellite technology. Gogo is early in the process of rolling out the new satellite technology.

Under its contract, American can potentially terminate its contract with Gogo if a competitor's equipment provides substantially better performance. However, Gogo also has the right to bid to upgrade its equipment to match the competitor's.

"We plan to submit a competing proposal to install our latest satellite technology—2Ku—on this fleet," Gogo said in the regulatory filing.

American filed suit Friday, notifying Gogo of a competitor's service.

Thursday, February 11, 2016

Proteostasis Therapeutics (PTI) began trading on the Nasdaq on 11 Feb 2016

CAMBRIDGE, Mass., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. today announced the closing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $8.00 per share. All of the shares sold in the offering were offered by Proteostasis Therapeutics, Inc. The company’s shares began trading on the NASDAQ Global Market on February 11, 2016 under the ticker symbol “PTI.” The gross proceeds from the offering are $50.0 million, before deducting underwriting discounts and commissions and expenses associated with the offering payable by the company.

Leerink Partners and RBC Capital Markets acted as joint book-running managers. Baird and H.C. Wainwright & Co. acted as co-managers.

Wednesday, February 3, 2016

=BeiGene (BGNE) began trading on the Nasdaq on 3 Feb 2016


  • BeiGene, a Chinese developer of drugs that target a body’s immune system to fight cancer. With a team of more than 215 scientists and other staff members, it is creating a pipeline of oral drugs and antibodies to treat cancer.
  • There were 84 biotech companies that went public in the United States in 2014, the largest number on record, while last year 50 such companies conducted IPOs, according to Dealogic.



BeiGene (NASDAQ: BGNE) opened for trading at $28.97 after pricing of its initial public offering of 6,600,000 American Depositary Shares (ADS), each representing 13 of its ordinary shares, par value $0.0001 per share, at an initial public offering price of $24.00 per ADS.

Goldman, Sachs & Co., Morgan Stanley and Cowen and Company are acting as joint book-running managers. Baird is acting as co-manager of the offering.

BeiGene is a global, clinical-stage, research-based biotechnology company focused on targeted and immuno-oncological therapeutics. With a team of 215+ scientists and staff, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is working to create combination solutions aimed to have both a meaningful and a lasting impact on cancer patients.